{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:41:29Z","timestamp":1773326489295,"version":"3.50.1"},"reference-count":12,"publisher":"Georg Thieme Verlag KG","issue":"12","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Neuropsiquiatr"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cerebral amyloid angiopathy (CAA) is a small vessel disease characterized by the deposition of amyloid-beta in small cerebral vessels, which can lead to intracerebral hemorrhages and cognitive impairment. Rare variants, such as cerebral amyloid angiopathy-related inflammation (CAA-ri) and iatrogenic CAA (ICAA), may mimic other neurological conditions and challenge diagnosis in clinical practice. We present three cases that illustrate distinct CAA syndromes, along with CSF biomarker analysis. One patient experienced recurrent hemorrhagic strokes with a history of dural graft, raising concerns about amyloid transmission. Two patients presented with rapidly progressive dementia that fulfilled CAA-ri criteria. All cases exhibited decreased levels of CSF A\u03b240 and A\u03b242, with one showing elevated p-tau, suggesting comorbid Alzheimer's pathology. Cerebrospinal fluid biomarkers complement neuroimaging in the diagnosis of CAA, aiding in differentiation from other dementias. Early recognition and diagnosis of CAA-ri variants is crucial, because immunotherapy may improve outcomes. Further research is necessary to establish biomarker thresholds and their clinical applicability.<\/jats:p>","DOI":"10.1055\/s-0045-1812887","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:40:37Z","timestamp":1764376837000},"page":"001-006","source":"Crossref","is-referenced-by-count":0,"title":["Cerebrospinal fluid biomarkers in cerebral amyloid angiopathy: insights from a clinical case series"],"prefix":"10.1055","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5048-351X","authenticated-orcid":false,"given":"Ana Silvia Sobreira Lima","family":"Verde","sequence":"additional","affiliation":[{"name":"Hospital Geral de Fortaleza, Departamento de Neurologia, Fortaleza CE, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6829-3239","authenticated-orcid":false,"given":"Alessandra Braga Cruz Guedes de","family":"Morais","sequence":"additional","affiliation":[{"name":"Hospital Geral de Fortaleza, Departamento de Neurologia, Fortaleza CE, Brazil."},{"name":"Universidade Federal de Sa\u0303o Paulo, Sa\u0303o Paulo SP, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7906-3772","authenticated-orcid":false,"given":"Amanda Vale","family":"Catunda","sequence":"additional","affiliation":[{"name":"Hospital Geral de Fortaleza, Departamento de Neurologia, Fortaleza CE, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2090-2582","authenticated-orcid":false,"given":"Jo\u00e3o Igor Dantas","family":"Landim","sequence":"additional","affiliation":[{"name":"Hospital Geral de Fortaleza, Departamento de Neurologia, Fortaleza CE, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5534-8015","authenticated-orcid":false,"given":"Ian Silva","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Hospital Geral de Fortaleza, Departamento de Neurologia, Fortaleza CE, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6828-9600","authenticated-orcid":false,"given":"Bruno Di\u00f3genes","family":"Iepsen","sequence":"additional","affiliation":[{"name":"Hospital Geral de Fortaleza, Departamento de Neurologia, Fortaleza CE, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2828-5664","authenticated-orcid":false,"given":"Norberto An\u00edzio Ferreira","family":"Frota","sequence":"additional","affiliation":[{"name":"Hospital Geral de Fortaleza, Departamento de Neurologia, Fortaleza CE, Brazil."},{"name":"Universidade de Fortaleza, Fortaleza CE, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"05","key":"ref1","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3390\/jcm14051697","article-title":"Clinical and Neuroradiological Manifestations of Cerebral Amyloid Angiopathy: A Closer Look into the Natural History of a Frequent Disease","volume":"14","author":"M Zedde","year":"2025","journal-title":"J Clin Med"},{"issue":"02","key":"ref2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jamaneurol.2015.4078","article-title":"Validation of Clinicoradiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-Related Inflammation","volume":"73","author":"E Auriel","year":"2016","journal-title":"JAMA Neurol"},{"issue":"18","key":"ref3","doi-asserted-by":"publisher","first-page":"e1809","DOI":"10.1212\/WNL.0000000000012778","article-title":"Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Prospective Longitudinal Cohort Study","volume":"97","author":"L Antolini","year":"2021","journal-title":"Neurology"},{"issue":"07","key":"ref4","doi-asserted-by":"publisher","first-page":"e209795","DOI":"10.1212\/WNL.0000000000209795","article-title":"Core CSF Biomarker Profile in Cerebral Amyloid Angiopathy: Updated Meta-Analysis","volume":"103","author":"A Charidimou","year":"2024","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-328792","article-title":"Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon","author":"G Banerjee","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"08","key":"ref6","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","article-title":"The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study","volume":"21","author":"A Charidimou","year":"2022","journal-title":"Lancet Neurol"},{"issue":"01","key":"ref7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/alz.12366","article-title":"Prevalence of cerebral amyloid angiopathy: A systematic review and meta-analysis","volume":"18","author":"L J\u00e4kel","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"01","key":"ref8","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3233\/ADR-220055","article-title":"Updated Outlook of Cerebral Amyloid Angiopathy and Inflammatory Subtypes: Pathophysiology, Clinical Manifestations, Diagnosis and Management","volume":"6","author":"B Singh","year":"2022","journal-title":"J Alzheimers Dis Rep"},{"issue":"04","key":"ref9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/ana.23857","article-title":"Anti-amyloid \u03b2 autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies","volume":"73","author":"F Piazza","year":"2013","journal-title":"Ann Neurol"},{"issue":"03","key":"ref10","doi-asserted-by":"publisher","first-page":"fcad159","DOI":"10.1093\/braincomms\/fcad159","article-title":"Cerebrospinal fluid biomarkers for cerebral amyloid angiopathy","volume":"5","author":"J A Sembill","year":"2023","journal-title":"Brain Commun"},{"issue":"05","key":"ref11","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1161\/STROKEAHA.122.041690","article-title":"Iatrogenic Cerebral Amyloid Angiopathy Post Neurosurgery: Frequency, Clinical Profile, Radiological Features, and Outcome","volume":"54","author":"K Kaushik","year":"2023","journal-title":"Stroke"},{"issue":"06","key":"ref12","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/ana.26610","article-title":"Decreased Cerebrospinal Fluid Amyloid \u03b2 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy","volume":"93","author":"A M De Kort","year":"2023","journal-title":"Ann Neurol"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0045-1812887.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:57:16Z","timestamp":1773277036000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0045-1812887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":12,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,7,15]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["s00451812887"],"URL":"https:\/\/doi.org\/10.1055\/s-0045-1812887","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0004-282X","1678-4227"],"issn-type":[{"value":"0004-282X","type":"print"},{"value":"1678-4227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]}}}